Scholars Central

Conference abstractPublished 21 Nov 2016

Vinca alkaloids induced peripheral neuropathy: Case series

Authors: Shahbaz Ahmad Khan, Abdul Hameed, Sahar Malik

Shaukat Khanum Cancer Hospital, Pakistan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of Problem: Peripheral neuropathy is one of the commonest side effects of vinca alkaloids due to decreased level of serum folate and vitamin B 12, underlying hepatic impairment and concurrent drugs which decrease vinca alkaloids hepatic metabolism. Although lot of research is done in western countries but incident is less studied in eastern population. The purpose of this study is to find out the etiology of vinca alkaloids induced peripheral neuropathy in local population. Research in our study was done on seven patients; case series of seven patients who suffered from vinca alkaloids induced periphweral neuropathy. Findings: Only one out of seven patients had low serum folate acid level while rest of the parameters were normal. Baseline renal hepatic functions were normal in the listed patients; most common symptoms were numbness and tingling of hands and feet. Weakness of arms or legs was also observed in some patients. Most patients developed these symptoms after 3-4 cycles of vinca alkaloids, showing a dose dependent pattern. Conclusions & Significance: The study findings are slightly contrary to data available which showed vinca alkaloids induced peripheral neuropathy associated with low serum folic acid level or deranged hepatic functions. More than half of the patients developed peripheral neuropathy after receiving at least 3 doses of vinca alkaloids. This seems in relation with the cumulative dose rather than after a single dose incident; almost all patients had advanced stage disease. Two patients later diagnosed to have CNS disease that may be contributing to symptoms of patients as well. So it is important to rule out CNS disease in non-Hodgkin lymphoma patients, in particular if PN symptoms are getting worse even after stopping the culprit agent. So it became very evident from the study that patients suffering PN had very different risk factors from those described in literature. Recommendations: As most of the literature and research work is done in western countries, the result from this study strongly emphasizes the need of research in eastern population and so that we may be able to find a comprehensive etiology to modify drug therapy accordingly.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Shahbaz Ahmad Khan”
  • BylineArticles whose byline prints “Abdul Hameed”
  • BylineArticles whose byline prints “Sahar Malik”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels